Previous 10 | Next 10 |
Baystreet news releases related Baystreet news releases and Baystreet press releases from 04/22/22 09:36:00 on US and Canada Markets.
Stock futures were lower in early morning trading Friday as the S&P 500 tried to avoid another losing week amid busy earnings and rising bond yields. Futures for the Dow Jones Industrials staggered 79 points, or 0.2%, to 34,630. Futures for the S&P 500 doffed five points...
Stocks fell Thursday in a sharp reversal, as a jump in Treasury yields offset the optimism coming from another batch of solid corporate earnings. The Dow Jones Industrials burrowed into negative territory 368.16 points, or 1.1%, to 34,792.63. The S&P 500 handed back 65.79 points...
A rally on Wall Street waned Thursday, as traders assessed rising rates ahead of remarks from Federal Reserve Chairman Jerome Powell. The Dow Jones Industrials came off its highs of the morning, but stayed afloat 47.74 points to 35,208.53. The S&P 500 ditched 2.08 points to 4,45...
Stocks rose sharply Thursday as investors digested more quarterly results, including strong earnings from Tesla, and awaited a policy speech from Federal Reserve Chairman Jerome Powell. The Dow Jones Industrials picked up from where it left off Wednesday, galloping 287.94 points to begi...
Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...
Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...
Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...
Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...
Stock futures rose in morning trading Thursday as investors digested more quarterly reports from the likes of Tesla and United Airlines and awaited a policy speech from Federal Reserve Chairman Jerome Powell. Futures for the Dow Jones Industrials screamed higher 240 points, or 0.7%,...
It was a divided market on Wednesday as traders evaluated a rush of first-quarter results. The Dow Jones Industrial Average rose on the back of strong earnings from Procter & Gamble, while the NASDAQ Composite was dragged down by an epic plunge in shares of one-time darling Netflix. ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.95%Change Percent:
Olin Corporation Company Name:
OLN Stock Symbol:
NYSE Market:
olin.com Website: